X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

DRUG

Closed

Bright Minds Biosciences Inc

26.58
+0.47 (+1.80%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 26.11
Day's Range: 25.2576 - 26.64
Send
When Written:
 
0.4401
Bright Minds Biosciences Inc. is a biotechnology company that specializes in the development of novel treatments for neuropsychiatric disorders. The company is focused on discovering and developing innovative therapies for conditions such as depression, anxiety, addiction, and schizophrenia, among others.

Bright Minds Biosciences uses a proprietary drug discovery platform based on a combination of computational modeling, machine learning, and experimental validation. This approach allows the company to identify and optimize drug candidates with high specificity and efficacy for their target diseases.

The company's lead drug candidate is a novel psychedelic compound with potential therapeutic applications in depression and anxiety. Bright Minds Biosciences is also exploring other compounds with potential applications in addiction and schizophrenia.

Bright Minds Biosciences was founded in 2018 and is headquartered in Vancouver, Canada. The company is led by a team of experienced biotech executives and scientists with a track record of successful drug development.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.209
X